Director Stock Options Grant

Steven T. Rosgen, a director at IMMUCELL CORP /DE/, was granted 10,000 non-qualified stock options on April 16, 2025. These options, exercisable until April 16, 2030, have an exercise price of $5.49 per share. The options were granted as compensation for his services on the board of directors. Following this transaction, Mr. Rosgen holds 10,000 shares of common stock underlying these options. The transaction is reported on Form 4.